News
Dr. Marty Makary, chief of the FDA, has expressed doubts about the agency approving the COVID-19 vaccine for winter, stating ...
There’s new uncertainty about updated COVID-19 shots this fall after the Trump administration’s handling of a shot from ...
Receiving a COVID-19 booster vaccine in the same arm as the first vaccine dose leads to a faster, more effective immune ...
Research teams across Canada are now building on homegrown innovation to expand the potential of RNA vaccines beyond ...
A Cleveland Clinic web page describing myocarditis survival rates was misrepresented online as news that millions who received COVID-19 vaccines were about to die.
Novavax's protein-only vaccine is once again expected to move from emergency approval to full approval status following a pause.
Trinity College Dublin researchers have found that the BNT162b2 COVID-19 vaccine may offer protection beyond its intended ...
Lawsuit backed by Secretary Kennedy’s former non-profit says CDC is forcing disadvantaged kids to be vaccinated.
Vaccines for the flu and COVID-19 can alter the menstrual cycle, but the impact is temporary and there is no reason for vaccine hesitancy, while breast cancer deaths among women ages 20 to 49 ...
3don MSN
The FDA has discussed with vaccine-maker Novavax the need for an additional trial of its COVID-19 vaccine as a post-approval ...
Related Articles FDA scrutiny of Novavax COVID-19 vaccine sparks uncertainty about other shots Stanford study: When measles could return if vaccination rates continue to fall Novavax says its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results